This suggests that liver and biliary dysfunction—evidenced by a decrease in aspartate aminotransferase (AST), an increase in alanine aminotransferase (ALT), and elevated gamma-glutamyl transpeptidase (γGTP) levels—may contribute to a progressive increase in IOP, independent of overt metabolic syndrome. This evidence concerns the gene GPT and metabolic syndrome.